Population pharmacokinetic study of pemetrexed in chinese primary advanced non-small cell lung carcinoma patients

• প্রধান লেখক: Peng Cao (লেখক), Wei Guo (লেখক), Jun Wang (লেখক), Sanlan Wu (লেখক), Yifei Huang (লেখক), Yang Wang (লেখক), Yani Liu (লেখক), Yu Zhang (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

The purposes of this study were to identify physiological and genetic factors that contributed to variability of pemetrexed (PEM) exposure and to optimize the dosing regimens for Chinese non-small cell lung carcinoma patients. A prospective population pharmacokinetics (PPK) research was performed in...